Latest News about BOLD
Recent news which mentions BOLD
The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
January 07, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 27, 2019
From Benzinga
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
December 27, 2019
From Benzinga
A Perspective On Biopharma's Record M&A Run In 2019
December 23, 2019
From Benzinga
Sarepta’s surprise FDA approval for rare disease drug excites investors
December 13, 2019
From MarketWatch
There’s more upside for biotech even after 24% gains in two months
December 12, 2019
From MarketWatch
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
December 12, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 11, 2019
From Benzinga
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
December 11, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 10, 2019
From Benzinga
Drugmakers have spent a record $342 billion on M&A in 2019
December 09, 2019
From MarketWatch
Benzinga's Top Upgrades, Downgrades For December 6, 2019
December 06, 2019
From Benzinga
The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
December 05, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 04, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 4, 2019
December 04, 2019
From Benzinga
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
December 04, 2019
From Benzinga
63 Biggest Movers From Yesterday
December 04, 2019
From Benzinga
Why Lands' End, Audentes Therapeutics, and ViewRay Jumped Today
December 03, 2019
From Motley Fool
Why Audentes Therapeutics Stock Is Skyrocketing Today
December 03, 2019
Tickers
BOLD
From Motley Fool
Mid-Afternoon Market Update: DarioHealth Jumps On Walmart Distribution Deal; Cara Therapeutics Shares Plummet
December 03, 2019
From Benzinga
Here's Why uniQure Is Rallying 13% Today
December 03, 2019
From Motley Fool
40 Stocks Moving In Tuesday's Mid-Day Session
December 03, 2019
From Benzinga
Mid-Day Market Update: Audentes Therapeutics Climbs On Acquisition News; ASLAN Pharmaceuticals Shares Slide
December 03, 2019
From Benzinga
The Gene Therapy Names Moving On The Audentes Buyout Deal
December 03, 2019
From Benzinga
PreMarket Prep Recap: Red On The Screen And Looking For More
December 03, 2019
From Benzinga
Astellas’ $3 billion gene therapy deal steadies investors after stalled Roche acquisition
December 03, 2019
From MarketWatch
Japan's Astellas To Buy Gene Therapy Company Audentes For $3B Cash
December 03, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 03, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.